In Polycythemia vera Polycythemia vera is a type of blood cancer that causes excessive production of red blood cells. This may lead to blood clot formation and lead to other serious health issues. Jakavi 20mg Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated. In Chronic idiopathic myelofibrosis Chronic idiopathic myelofibrosis is a long-term problem that causes fibrous, or scar, tissue to form in the bone marrow. The scarring means the bone marrow can't work normally and produces fewer red blood cells and usually too many white blood cells. Jakavi 20mg Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. You may experience some bothersome side effects. Discuss with your doctor if you have any doubts.
Consuming alcohol with Jakavi 20mg Tablet does not cause any harmful side effects.
Jakavi 20mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Jakavi 20mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Jakavi 20mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Jakavi 20mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Jakavi 20mg Tablet may be needed. Please consult your doctor. Use of Jakavi 20mg Tablet is not advised in patients with moderate to severe kidney disease.
Jakavi 20mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Jakavi 20mg Tablet may be needed. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More